BioCentury
ARTICLE | Clinical News

MLB reports Phase II Devacade data

August 20, 2001 7:00 AM UTC

ML Laboratories (LSE:MLB) said that its Devacade opiate in combination with standard therapy gave significantly improved pain relief compared to standard therapy alone in half the patients receiving t...